Osemitamab, CAS 2460539-61-9

Product Description: Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 γ1-chain, disulfide with human-Mus musculus monoclonal TST001 κ-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Shen L, et al. Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002)[J]. 2023./[2]Park Soon Jae, et al. Pharmaceutical composition comprising human hyaluronidase PH20 variants for drug delivery system via subcutaneous injection. World Intellectual Property Organization, WO2023075506 A1. 2023-05-04.

CAS Number: 2460539-61-9

Molecular Weight: N/A

Compound Purity: 97.26

Research Area: Cancer

Solubility: 10 mM in DMSO/H2O

Target: Others

• Artikelnummer: MEXHY-P9991-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9991-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated